+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Wearable Injectors Market by Product and Geography - Forecast and Analysis 2020-2024 - Product Image

Wearable Injectors Market by Product and Geography - Forecast and Analysis 2020-2024

  • ID: 4858674
  • Report
  • November 2019
  • Region: Global
  • 144 pages
  • TechNavio

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Amgen Inc.
  • Becton
  • Dickinson and Co.
  • Enable Injections Inc.
  • Gerresheimer AG
  • Insulet Corp.
  • MORE
Global Wearable Injectors Market: About this market

The author's wearable injectors market analysis considers sales from on-body wearable injectors and off-body wearable injectors products. Our study also finds the sales of wearable injectors in Asia, Europe, North America, and ROW. In 2019, the on-body wearable injectors segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as the convenience of self-administration of drugs and increasing prevalence of cancer, diabetes, and other chronic diseases will play a significant role in the on-body wearable injectors segment to maintain its market position. Also, our global wearable injectors market report looks at factors such as increasing prevalence of chronic diseases, increasing number of new product launches, and increasing demand for self-administrative drug delivery devices. However, presence of alternative methods for drug delivery, high costs associated with wearable injectors, and cybersecurity concerns related to wearable injectors may hamper the growth of the wearable injectors industry over the forecast period.

Global Wearable Injectors Market: Overview

Increasing demand for self-administrative drug delivery devices
Specific drug delivery systems have recently become available for patients, which facilitate self-administration and thus, ensure patient’s adherence to medication. Self-administration of drugs improves health outcomes and reduces the admission rate at hospitals and clinics for regular treatment. A wearable injector is a specific type of self-injector drug delivery device that is widely accepted by healthcare professionals and patients worldwide. Thus, the increasing demand for self-administrative drug delivery devices will lead to the expansion of the global wearable injectors market at a CAGR of almost 11% during the forecast period.

Technological advancements in wearable injectors
Wearable injectors are preferred self-injection devices, which are primarily used in healthcare settings for the treatment of patients with diabetes, cancer, arthritis, and autoimmune diseases. They are widely accepted by patients with diabetes and pain due to various medical reasons. These advanced injectable devices facilitate accurate and automatic delivery of drugs in high volume and with high viscosity. Most pharmaceutical and medical device companies are focusing on new technologies that can enhance the effectiveness and accuracy of the medication by minimizing the frequency of injections for drug delivery with regular injectors and syringes. This development is expected to have a positive impact on the overall market growth.

Competitive Landscape
With the presence of several major players, the global wearable injectors market is fragmented. The author's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading wearable injectors manufacturers, that include Amgen Inc., Becton, Dickinson, and Co., Enable Injections Inc., Gerresheimer AG, Insulet Corp., Medtronic Plc, Tandem Diabetes Care Inc., Valeritas Inc., West Pharmaceutical Services Inc., and Ypsomed AG.

Also, the wearable injectors market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen Inc.
  • Becton
  • Dickinson and Co.
  • Enable Injections Inc.
  • Gerresheimer AG
  • Insulet Corp.
  • MORE
PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT
  • Preface
  • Preface
  • Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
  • Market ecosystem
  • Market characteristics
  • Value chain analysis
  • Market segmentation analysis
PART 04: MARKET SIZING
  • Market definition
  • Market sizing 2019
  • Market size and forecast 2019-2024
  • Market outlook
PART 05: FIVE FORCES ANALYSIS
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
  • Market segmentation by product
  • Comparison by product
  • On-body wearable injectors - Market size and forecast 2019-2024
  • Off-body wearable injectors - Market size and forecast 2019-2024
  • Market opportunity by product
PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE
  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2019-2024
  • Europe - Market size and forecast 2019-2024
  • Asia - Market size and forecast 2019-2024
  • ROW - Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity
PART 09: DECISION FRAMEWORK

PART 10: DRIVERS AND CHALLENGES
  • Market drivers
  • Market challenges
PART 11: MARKET TRENDS
  • Technological advancements in wearable injectors
  • Increasing number of partnerships and collaborations
  • Increasing focus on development of biologics
PART 12: VENDOR LANDSCAPE
  • Overview
  • Landscape disruption
  • Competitive scenario
PART 13: VENDOR ANALYSIS
  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Amgen Inc.
  • Becton, Dickinson and Co.
  • Enable Injections Inc.
  • Gerresheimer AG
  • Insulet Corp.
  • Medtronic Plc
  • Tandem Diabetes Care Inc.
  • Valeritas Inc.
  • West Pharmaceutical Services Inc.
  • Ypsomed AG
PART 14: APPENDIX
  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors
List of Exhibits 
Exhibit 01: Global healthcare supplies market
Exhibit 02: Segments of global healthcare supplies market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Product overview
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2019
Exhibit 18: Product - Market share 2019-2024 (%)
Exhibit 19: Comparison by product
Exhibit 20: On-body wearable injectors - Market size and forecast 2019-2024 ($ millions)
Exhibit 21: On-body wearable injectors - Year-over-year growth 2020-2024 (%)
Exhibit 22: Off-body wearable injectors - Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Off-body wearable injectors - Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America - Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America - Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe - Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe - Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia - Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia - Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW - Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW - Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Product launch details and market impact analysis
Exhibit 39: Impact of drivers and challenges
Exhibit 40: Vendor landscape
Exhibit 41: Landscape disruption
Exhibit 42: Vendors covered
Exhibit 43: Vendor classification
Exhibit 44: Market positioning of vendors
Exhibit 45: Amgen Inc. - Vendor overview
Exhibit 46: Amgen Inc. - Business segments
Exhibit 47: Amgen Inc. - Organizational developments
Exhibit 48: Amgen Inc. - Geographic focus
Exhibit 49: Amgen Inc. - Key offerings
Exhibit 50: Amgen Inc. - Key customers
Exhibit 51: Becton, Dickinson and Co. - Vendor overview
Exhibit 52: Becton, Dickinson and Co. - Product segments
Exhibit 53: Becton, Dickinson and Co. - Organizational developments
Exhibit 54: Becton, Dickinson and Co. - Geographic focus
Exhibit 55: Becton, Dickinson and Co. - Segment focus
Exhibit 56: Becton, Dickinson and Co. - Key offerings
Exhibit 57: Becton, Dickinson and Co. - Key customers
Exhibit 58: Enable Injections Inc. - Vendor overview
Exhibit 59: Enable Injections Inc. - Product segments
Exhibit 60: Enable Injections Inc. - Organizational developments
Exhibit 61: Enable Injections Inc. - Key offerings
Exhibit 62: Enable Injections Inc. - Key customers
Exhibit 63: Gerresheimer AG - Vendor overview
Exhibit 64: Gerresheimer AG - Business segments
Exhibit 65: Gerresheimer AG - Organizational developments
Exhibit 66: Gerresheimer AG - Geographic focus
Exhibit 67: Gerresheimer AG - Segment focus
Exhibit 68: Gerresheimer AG - Key offerings
Exhibit 69: Gerresheimer AG - Key customers
Exhibit 70: Insulet Corp. - Vendor overview
Exhibit 71: Insulet Corp. - Business segments
Exhibit 72: Insulet Corp. - Organizational developments
Exhibit 73: Insulet Corp. - Geographic focus
Exhibit 74: Insulet Corp. - Key offerings
Exhibit 75: Insulet Corp. - Key customers
Exhibit 76: Medtronic Plc - Vendor overview
Exhibit 77: Medtronic Plc - Business segments
Exhibit 78: Medtronic Plc - Organizational developments
Exhibit 79: Medtronic Plc - Segment focus
Exhibit 80: Medtronic Plc - Key offerings
Exhibit 81: Medtronic Plc - Key customers
Exhibit 82: Tandem Diabetes Care Inc. - Vendor overview
Exhibit 83: Tandem Diabetes Care Inc. - Business segments
Exhibit 84: Tandem Diabetes Care Inc. - Organizational developments
Exhibit 85: Tandem Diabetes Care Inc. - Key offerings
Exhibit 86: Tandem Diabetes Care Inc. - Key customers
Exhibit 87: Valeritas Inc. - Vendor overview
Exhibit 88: Valeritas Inc. - Business segments
Exhibit 89: Valeritas Inc. - Organizational developments
Exhibit 90: Valeritas Inc. - Key offerings
Exhibit 91: Valeritas Inc. - Key customers
Exhibit 92: West Pharmaceutical Services Inc. - Vendor overview
Exhibit 93: West Pharmaceutical Services Inc. - Business segments
Exhibit 94: West Pharmaceutical Services Inc. - Organizational developments
Exhibit 95: West Pharmaceutical Services Inc. - Geographic focus
Exhibit 96: West Pharmaceutical Services Inc. - Segment focus
Exhibit 97: West Pharmaceutical Services Inc. - Key offerings
Exhibit 98: West Pharmaceutical Services Inc. - Key customers
Exhibit 99: Ypsomed AG - Vendor overview
Exhibit 100: Ypsomed AG - Business segments
Exhibit 101: Ypsomed AG - Organizational developments
Exhibit 102: Ypsomed AG - Geographic focus
Exhibit 103: Ypsomed AG - Segment focus
Exhibit 104: Ypsomed AG - Key offerings
Exhibit 105: Ypsomed AG - Key customers
Exhibit 106: Validation techniques employed for market sizing
Exhibit 107: Definition of market positioning of vendors
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen Inc.
  • Becton
  • Dickinson and Co.
  • Enable Injections Inc.
  • Gerresheimer AG
  • Insulet Corp.
  • MORE
The author recognizes the following companies as the key players in the global wearable injectors market: Amgen Inc., Becton, Dickinson, and Co., Enable Injections Inc., Gerresheimer AG, Insulet Corp., Medtronic Plc, Tandem Diabetes Care Inc., Valeritas Inc., West Pharmaceutical Services Inc., and Ypsomed AG.

Commenting on the report, an analyst from the author said: “The latest trend gaining momentum in the market is the technological advancements in wearable injectors.”

According to the report, one of the major drivers for this market is the increasing demand for self-administrative drug delivery devices.

Further, the report states that one of the major factors hindering the growth of this market is the presence of alternative methods for drug delivery.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
  • Amgen Inc.
  • Becton
  • Dickinson and Co.
  • Enable Injections Inc.
  • Gerresheimer AG
  • Insulet Corp.
  • Medtronic Plc
  • Tandem Diabetes Care Inc.
  • Valeritas Inc.
  • West Pharmaceutical Services Inc.
  • Ypsomed AG.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll